Japan’s health ministry approved on Friday the use of rheumatoid arthritis drug Baricitinib for COVID-19 patients, the third such approval following the drugs remdesivir and dexamethasone.
Eli Lilly & Co’s Japan subsidiary had applied to regulators for the new use of the drug in December.
Follow us on:
Australia has approved the extradition of ex-marine Daniel Duggan, facing US charges for allegedly training…
Donald Trump has selected businessman Tilman Fertitta, owner of the Houston Rockets, to serve as…
A plane crash in Gramado, Brazil, killed ten family members, including businessman Luiz Claudio Galeazzi,…
A suspect has been apprehended in Brooklyn subway after woman was set ablaze and died…
A Brazilian bridge collapse has killed one person and spilled sulfuric acid into the Tocantins…
Governor Soludo has expressed grief over Okija stampede, urges safety-first approach for future food distribution…